Status:
TERMINATED
Horyzons: Implementation and Integration in Clinical Practice
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
North Carolina Department of Health and Human Services
Conditions:
Schizophrenia
Schizophreniform Disorders
Eligibility:
All Genders
16-35 years
Phase:
NA
Brief Summary
The primary aim of this trial is evaluating the barriers and enablers of implementing a digital intervention with both therapeutic content and social networking, Horyzons, as part of clinical care in ...
Detailed Description
Purpose: The primary objective is to assess the barriers and facilitators of integrating Horyzons, an evidence-based digital intervention, in outpatient mental health clinics in North Carolina that pr...
Eligibility Criteria
Inclusion
- CLIENT PARTICIPANTS
- Clients must be between the ages of 16 and 35
- Clients must have a diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, or Unspecified Schizophrenia Spectrum or Other Psychotic disorder
- Clients must be receiving services at one of the five FEP clinics in North Carolina (OASIS, Encompass, Eagle, SHORE, or AEGIS) or one of their stepdown outpatient clinics (STEP and TIDES)
- Client not having any active thoughts of harming self in the month prior to enrollment
- Clients must not have been hospitalized for psychiatric reasons in the three months before enrollment
- Clients must actively be engaging with medication management through their clinic
- Clients must have access to the internet through a phone, tablet, or computer
Exclusion
- Clients who do not speak English will not be considered for enrollment
- Adult client with legal guardians where one or both the individual and legal guardian do not provide consent for the individual to participate
- PROVIDER PARTICIPANTS
- Inclusion Criteria:
- Provider \&/or PSS must be 18 years or older
- Provider \&/or PSS must be currently serving clients within their FEP clinic
- Provider \&/or PSS must be able to speak and read English
Key Trial Info
Start Date :
January 8 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2024
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06002958
Start Date
January 8 2024
End Date
October 31 2024
Last Update
September 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27599